Seven Ways to Preserve the Miracle of Antibiotics

被引：275

作者：

Bartlett, John G. ^{[1
]}

Gilbert, David N. ^{[2
]}

Spellberg, Brad ^{[3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA

[2] Providence Portland Med Ctr, Dept Med Educ, Portland, OR USA

[3] Liu Vaccine Ctr, Torrance, CA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2013年 / 56卷 / 10期

关键词：

antibiotic resistance; antibiotic salvage; European Union; stewardship; molecular diagnostics; DOUBLE-BLIND; ANTIMICROBIALS; SURVEILLANCE; PNEUMONIA;

D O I：

10.1093/cid/cit070

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Antibiotic resistance is a well-acknowledged crisis with no clearly defined comprehensive, national corrective plan. We propose a number of interventions that, collectively, could make a large difference. These include collection of data to inform decisions, efforts to reduce antibiotic abuse in people and animals, great emphasis on antibiotic stewardship, performance incentives, optimal use of newer diagnostics, better support for clinical and basic resistance-related research, and novel methods to foster new antibiotic development.

引用

页码：1445 / 1450

页数：6

共 41 条

[11] Pharmacokinetics and pharmacodynamics of antimicrobials
Drusano, G. L.
[J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 : S89 - S95
[12] Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study
el Moussaoui, Rachida
de Borgie, Corianne A. J. M.
van den Broek, Peterhans
Hustinx, Willem N.
Bresser, Paul
van den Berk, Guido E. L.
Poley, Jan-Werner
van den Berg, Bob
Krouwels, Frans H.
Bonten, Marc J. M.
Weenink, Carla
Bossuyt, Patrick M. M.
Speelman, Peter
Opmeer, Brent C.
Prins, Jan M.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7554): : 1355 - 1358
[13] Fleming A., 1945, NY TIMES, V21
[14] The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
Gilbert, David N.
Guidos, Robert J.
Boucher, Helen W.
Talbot, George H.
Spellberg, Brad
Edwards, John E., Jr.
Scheld, W. Michael
Bradley, John S.
Bartlett, John G.
[J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1081 - 1083
[15] Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267
[16] Monitoring seasonal influenza A evolution: Rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay
Jeng, Kevin
Massire, Christian
Zembower, Teresa R.
Deyde, Varough M.
Gubareva, Larisa V.
Hsieh, Yu-Hsiang
Rothman, Richard E.
Sampath, Rangarajan
Penugonda, Sudhir
Metzgar, David
Blyn, Lawrence B.
Hardick, Justin
Gaydos, Charlotte A.
[J]. JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (04) : 332 - 336
[17] Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods
Johansson, Niclas
Kalin, Mats
Tiveljung-Lindell, Annika
Giske, Christian G.
Hedlund, Jonas
[J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) : 202 - 209
[18] Food Animals and Antimicrobials: Impacts on Human Health
Marshall, Bonnie M.
Levy, Stuart B.
[J]. CLINICAL MICROBIOLOGY REVIEWS, 2011, 24 (04) : 718 - +
[19] The Challenges of Antimicrobial Drug Resistance in Greece
Miyakis, Spiros
Pefanis, Angelos
Tsakris, Athanassios
[J]. CLINICAL INFECTIOUS DISEASES, 2011, 53 (02) : 177 - 184
[20] National Institute for Public Health and the Environment

← 1 2 3 4 5 →